Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients

BACKGROUND: Numerous studies have shown that dipeptidyl peptidase-4 inhibitors (DPP-4i) may regulate immunological pathways implicated in asthma. The association between DPP-4i use and risk of asthma development is limited, however. AIM: We aimed to evaluate if DPP-4i treatment in individuals with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peng-Fei, Chung, Chi-Hsiang, Liu, Jhih-Syuan, Lu, Chieh-Hua, Su, Sheng-Chiang, Kuo, Feng-Chih, Ho, Li-Ju, Chen, Kuan-Chan, Su, Yu-Te, Chu, Nain-Feng, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Hung, Yi-Jen, Lin, Fu-Huang, Chien, Wu-Chien, Liang, Yao-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716455/
https://www.ncbi.nlm.nih.gov/pubmed/36448591
http://dx.doi.org/10.1177/17534666221135320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716455/
https://www.ncbi.nlm.nih.gov/pubmed/36448591
http://dx.doi.org/10.1177/17534666221135320

Ejemplares similares